Kidney News and Research

RSS

Immunotherapy side effect could signal improved control of kidney cancer

An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP).

2 Nov 2020

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

This new study titled, "Remdesivir Metabolite GS-441524 Efficiently Inhibits SARS-CoV-2 Infection in Mouse Model," was released online as a preprint on the bioRxiv* server, prior to undergoing the peer-review process.

2 Nov 2020

Researchers develop a unique method of identifying early signs of acute kidney injury

Researchers at the University of Liverpool have identified a unique method of identifying the early signs of a potentially serious condition known as Acute Kidney Injury (AKI).

2 Nov 2020

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Children with multiple islet autoantibodies - biological markers of autoimmunity -- are more likely to progress to symptomatic type 1 diabetes (T1D) than those who remain positive for a single autoantibody.

30 Oct 2020

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A recent study published on the preprint server medRxiv* in October 2020 shows the need for large-scale studies on the clinical characteristics and outcomes of COVID-19 at the national and international scale. This is essential to shape interventions and optimize the use of resources to contain and manage a second wave of the pandemic.

30 Oct 2020

Study suggests new strategies to prevent complications in cardiac patients

Patients in cardiac intensive care units (CICUs) could benefit from the CICU health care team using a daily checklist to prevent infections and other common complications.

29 Oct 2020

Glucose-lowering drug can protect the kidneys in patients with type 1 diabetes, study shows

A glucose-lowering drug commonly used in patients with type 2 diabetes, can protect the kidneys in patients with type 1 diabetes. According to results shown in a new study published in the Lancet.

28 Oct 2020

If Trump wins, don’t hold your breath waiting for that ACA replacement plan

If President Donald Trump wins reelection next week, it seems unlikely he will unveil the health plan he's been promising since before his election in 2016. Still, other aspects of health care could be featured in his second-term agenda.

27 Oct 2020

New app tracks nutrition data in kidney and heart disease patients

The best way to manage conditions like kidney and heart disease is to manage one's diet in accordance with medical recommendations to limit the intake of certain nutrients.

27 Oct 2020

Transcriptomics identifies possible COVID-19 therapies

By using a diverse set of transcriptomic SARS-CoV-2 signatures, US researchers put to use their previously developed drug repositioning pipeline to pinpoint potential drug candidates for the treatment of coronavirus disease (COVID-19). The study is currently available on bioRxiv preprint server.

26 Oct 2020

Researchers identify molecular processes in kidney cells that attract and feed COVID-19

Although the lungs are a common target for COVID-19's cytokine storm, so are the kidneys, making the 1 in 4 U.S. adults with diabetes resulting in diabetic kidney disease at increased risk for virus mortality.

23 Oct 2020

Molecular processes in kidney cells may increase diabetics' vulnerability to COVID-19 infection

People with diabetes -- especially the 20 to 40 percent with diabetic kidney disease -- are among the most at risk for serious complications and death from COVID-19.

23 Oct 2020

High-impact clinical trial results could improve kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented online during ASN Kidney Week 2020 Reimagined October 19-October 25.

23 Oct 2020

Investigational drug offers benefits for patients with chronic kidney disease and type 2 diabetes

The findings, simultaneously published in the New England Journal of Medicine and presented at the American Society of Nephrology's Kidney Week 2020 conference, show the investigational drug finerenone had tangible renal and cardiovascular benefits for patients with chronic kidney disease and type 2 diabetes.

23 Oct 2020

COVID spikes exacerbate health worker shortages in Rocky Mountains, Great Plains

COVID-19 cases are surging in rural places across the Mountain States and Midwest, and when it hits health care workers, ready reinforcements aren't easy to find.

23 Oct 2020

Vitamin C and COVID-19: A Review

In a recent review published in Preprints*, Patrick Holford et al. address vitamin C's role as adjunctive therapy for respiratory infection, sepsis, and COVID-19.

23 Oct 2020

Researchers show a simple way to protect transplanted islets from rejection

Type 1 diabetes, or T1D, results from the autoimmune destruction of the insulin-producing cells of the pancreas. People with T1D require exogenous insulin and suffer swings in the levels of glucose in the blood that impact life expectancy and increase risks of cardiovascular disease, neuropathies and kidney failure.

22 Oct 2020

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine.

22 Oct 2020

More than 2.5 million person-years of life lost in US due to COVID-19

In a recently published study, researcher Stephen Elledge from Harvard Medical School has described converting the coronavirus disease (COVID-19) death toll from individual deaths to “person-years” lost in order to provide a more accurate picture of the pandemic’s toll on the population.

21 Oct 2020

UC study shows how tobacco use impacts patients with kidney cancer

Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

20 Oct 2020

Kidney News and Research

Immunotherapy side effect could signal improved control of kidney cancer

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Researchers develop a unique method of identifying early signs of acute kidney injury

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

Study suggests new strategies to prevent complications in cardiac patients

Glucose-lowering drug can protect the kidneys in patients with type 1 diabetes, study shows

If Trump wins, don’t hold your breath waiting for that ACA replacement plan

New app tracks nutrition data in kidney and heart disease patients

Transcriptomics identifies possible COVID-19 therapies

Researchers identify molecular processes in kidney cells that attract and feed COVID-19

Molecular processes in kidney cells may increase diabetics' vulnerability to COVID-19 infection

High-impact clinical trial results could improve kidney-related medical care

Investigational drug offers benefits for patients with chronic kidney disease and type 2 diabetes

COVID spikes exacerbate health worker shortages in Rocky Mountains, Great Plains

Vitamin C and COVID-19: A Review

Researchers show a simple way to protect transplanted islets from rejection

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

More than 2.5 million person-years of life lost in US due to COVID-19

UC study shows how tobacco use impacts patients with kidney cancer

Free guide - Everything about renal proximal tubule cells eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News